APOE and glioblastoma: ApoE‐modified nanocapsules exhibited strong GBM cell recognition and inhibited glycolysis energy production through PKM2 gene knockdown effect thereby promoting chemosensitization of temozolomide.[59] In glial cells, the inflammatory or tumor microenvironment causes glial cells to develop an activated state that alters the expression of proteins on their surface.